AXS Rule 144 Notice — 2,200 Shares Sold via Morgan Stanley on NYSE
Rhea-AI Filing Summary
Form 144 notice for Axis Capital Holders Limited (AXS): The filing reports a proposed sale of 2,200 common shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $211,200.00. The shares represent part of restricted stock that vested on 03/01/2024 (1,407 shares) and 03/01/2023 (793 shares). The filer previously sold the same 2,200 shares on 08/15/2025 in four transactions, producing combined gross proceeds of $211,463.78. The form includes the standard signer representation that no undisclosed material adverse information is known.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider sale disclosed under Rule 144; quantity is small relative to total shares outstanding.
The filing documents an insider disposing of 2,200 common shares via a broker on the NYSE, with the securities originating from restricted stock vesting in 2023 and 2024. The reported shares outstanding are 78,173,983, so the sale equals a de minimis percentage of outstanding stock. The notice lists both the proposed sale details and actual sales on 08/15/2025 with gross proceeds reported. For investors, this is a transparency event showing insider liquidity rather than a material corporate development.
TL;DR: Filing appears to comply with Rule 144 disclosure requirements and includes required signer attestations.
The form identifies the broker, number of shares, market value, share origin (restricted stock vesting), and prior sales in the past 3 months, matching Rule 144 presentation standards. The signer affirms absence of undisclosed material adverse information. No regulatory exceptions or incomplete mandatory fields are evident in the provided content, though some issuer identity fields in the extract are blank or not shown.